Previous close | 6.20 |
Open | 6.20 |
Bid | 6.25 x 400 |
Ask | 6.28 x 400 |
Day's range | 6.10 - 6.29 |
52-week range | 3.06 - 6.76 |
Volume | |
Avg. volume | 2,567,291 |
Market cap | 1.453B |
Beta (5Y monthly) | 0.43 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.13 |
Earnings date | 08 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 8.38 |
In the most recent trading session, Adma Biologics (ADMA) closed at $6.27, indicating a +1.13% shift from the previous trading day.
Data from a mid-stage study show that Sage's (SAGE) experimental oral drug failed to show a statistically significant difference in treating patients with Parkinson's disease compared with a placebo.
In the most recent trading session, Adma Biologics (ADMA) closed at $6.04, indicating a -1.95% shift from the previous trading day.